Clariant is a world leader in specialty chemicals headquartered in Muttenz near Basel, Switzerland. On December 31, 2016, the company had 17,442 employees in total. In the 2016 financial year, Clariant generated sales of CHF 5.847 billion with its continuing businesses. The company reports in four business areas: Care Chemicals, Catalysis, Natural Resources, and Plastics & Coatings. Clariant's corporate strategy is based on five pillars: focus on innovation through research and development; add value while ensuring sustainability; reposition the portfolio; intensify growth and boost profitability.
Headquartered in Frankfurt, Germany, Infraserv Höchst operates advanced infrastructure for companies in the chemical, pharmaceutical and related process industries. Infraserv Höchst leverages its experience and capabilities in site operation, management and consulting to deliver site excellence for its customers. The company, which operates sites such as Industriepark Höchst, offers services in utilities, waste management, logistics and site services.
The wholly owned subsidiaries in the Infraserv Höchst Group include Infraserv Logistics and Provadis Partner für Bildung und Beratung.
Infraserv GmbH & Co. Höchst KG has around 1,800 employees and 132 trainees on its payroll. The entire Infraserv Höchst Group has some 2,500 employees and 162 trainees. Infraserv Höchst and its subsidiaries generated around EUR 945 million in revenue in 2016.
Established in 1991, Kuraray Europe GmbH is based in Hattersheim, near Frankfurt am Main, Germany. In 2016 the company generated annual sales of over EUR 600 million. It has 660 employees in Germany at its sites in Hattersheim, Frankfurt and Troisdorf. Kuraray is a global specialty chemicals company and one of the largest suppliers of polymers and synthetic microfibers, including KURARAY POVAL™, Mowital®, Trosifol® and CLEARFIL™, for many sectors of industry. Kuraray Europe also has 180 employees at six other European sites. They also work on the development and application of innovative high-performance materials for a wide range of sectors, including the automotive, paper, glass and packaging industries, as well as for architects and dentists.
Kuraray Europe is a wholly owned subsidiary of the publicly listed Kuraray Group, which is based in Tokyo, Japan, and has around 10,000 employees worldwide and sales of over EUR 4 billion.
Sanofi is a global healthcare leader. It employs over 110,000 people in more than 100 countries, all working towards saving and improving the lives of millions of patients around the world. Germany is one of the company’s most important business locations after the US and its French home market. Of the ten largest pharmaceutical companies worldwide, Sanofi is the only one to cover the entire pharmaceutical value chain in Germany and maintain significant research and manufacturing operations in the country.
Sanofi-Aventis Deutschland GmbH is the German subsidiary of one of the world's healthcare leaders and the largest employer at Industriepark Höchst. In 2016, Sanofi generated EUR 4.7 billion in sales in Germany with innovative, cutting-edge drugs, established original preparations, over-the-counter medications and generic products. Domestic pharmacies and hospitals accounted for EUR 948 million of this total, while EUR 2,799 million came from exporting active pharmaceutical ingredients and drug products that were manufactured in Germany and EUR 604 million were generated through services provided for other subsidiaries.
Frankfurt-Höchst is Sanofi-Aventis Deutschland GmbH’s headquarters and largest location as well as a network like no other in the Sanofi Group. From basic research to drug shipment, it covers everything needed to supply medicines to the German market and 100 other countries worldwide. About 7,900 members of the company’s 9,800-strong German workforce are located in Frankfurt-Höchst, where they work in research and development, production and manufacturing, and administration.